NIH-funded research NIH-funded research

Improving deep brain stimulation for Parkinson's disease using biomarkers

Official title: An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease

Funded at Duke University · NIH-11019683 · Data updated 2026-11-12

This study is looking at a new way to make deep brain stimulation for Parkinson's disease even better by using real-time signals from your body to automatically adjust the treatment, which could help reduce symptoms like tremors and stiffness for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startFebruary 15, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$910,776
NIH project number5UH3NS129898-03
Project IDNIH-11019683 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are considering or currently undergoing deep brain stimulation therapy.

Less likely to help

Patients who do not have Parkinson's disease or those who are not candidates for deep brain stimulation therapy may not benefit from this research.

What this research studies

This research investigates how to enhance deep brain stimulation (DBS) therapy for Parkinson's disease by using physiological biomarkers to adjust stimulation parameters automatically. The approach aims to personalize treatment by recording signals related to motor symptoms and dynamically adjusting the stimulation in real-time. By integrating multiple biomarkers, the study seeks to optimize DBS therapy over various time scales, potentially leading to better management of symptoms like tremors and rigidity. Patients may experience improved outcomes through this innovative method of treatment.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with Parkinson's disease.

How similar studies have gone: Previous research has shown promise in using adaptive DBS techniques, indicating potential for success with this integrated biomarker approach.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Turner, Dennis Alan — Duke University
  • Study coordinator: Turner, Dennis Alan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.